Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Submitted by
admin
on January 26, 2016 - 9:01pm
Source:
Fierce Pharma
News Tags:
Amgen
biosimilars
Humira
FDA
AbbVie
Headline:
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Do Not Allow Advertisers to Use My Personal information
